S'abonner

Incarcerated gravid uterus: a new treatment using the transvaginal ultrasound probe and narrative literature review - 18/09/24

Doi : 10.1016/j.ajog.2024.08.026 
Agata Kantorowska, MD a, , Elizabeth T. Patberg, MD, MA b, Fatima Ali, DO c, Anju Suhag, MD a, Patricia Rekawek, MD a, Anthony M. Vintzileos, MD d, e, f, Martin R. Chavez, MD a
a Department of Obstetrics and Gynecology, NYU Langone Hospital-Long Island, NYU Grossman Long Island School of Medicine, Mineola, NY 
b Department of Obstetrics, Gynecology and Reproductive Services, University of California San Francisco, San Francisco, CA 
c Department of Obstetrics and Gynecology, Wayne State University School of Medicine/Detroit Medical Center, Detroit, MI 
d Department of Obstetrics and Gynecology, Northwell, New Hyde Park, NY 
e Department of Obstetrics and Gynecology, Lenox Hill Hospital, New York, NY 
f Zucker School of Medicine, Uniondale, NY 

Corresponding author: Agata Kantorowska, MD.
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 18 September 2024

Abstract

Background

‘Incarcerated gravid uterus’ is a morbid complication that occurs in 1 in 3000 pregnancies. It is characterized by failure of a retropositioned uterus to become an abdominal organ between 12 to 14 weeks of gestation. If maternal symptoms develop or gestational age surpasses 14 to 16 weeks, replacement of a retropositioned uterus is recommended to reduce adverse outcomes. Previously described techniques for management include passive reduction, digital replacement, or more invasive methods such as laparoscopy, laparotomy, or sigmoidoscopy. These methods are either minimally effective, painful, or risky.

Objective

The objective of this report is to describe our clinical experience with a new minimally invasive technique that uses the transvaginal ultrasound probe for uterine replacement in cases of incarceration, to conduct a narrative literature review on ‘incarcerated gravid uterus,’ and to propose an algorithm for management of this condition.

Study Design

This is a case series of 8 patients with an incarcerated gravid uterus who were managed with the transvaginal ultrasound probe technique at one academic medical institution between March 2020 and July 2023, as well as a narrative review of the literature on ‘incarcerated gravid uterus.’ PubMed, Google Scholar, and Ovid MEDLINE databases were searched for the terms “incarcerated gravid uterus,” “uterine incarceration,” “uterine sacculation,” and “retroverted uterus” up to April 2024.

Results

The transvaginal ultrasound probe technique resulted in successful uterine replacement, with resolution of symptoms, in all 8 patients. All pregnancies resulted in live births with good neonatal outcomes—7 out of 8 patients delivered at term, and 1 delivered in the late preterm period.

Conclusion

Our proposed technique for treatment of an incarcerated gravid uterus with the transvaginal ultrasound probe is simple, minimally invasive and effective. Based on our experience and the narrative literature review, an algorithm for the management of an incarcerated gravid uterus is proposed.

Le texte complet de cet article est disponible en PDF.

Video


(38.94 Mo)

Le texte complet de cet article est disponible en PDF.

Key words : adverse pregnancy outcomes, impacted uterus, miscarriage, pregnancy complications, retroflexed, retropositioned uterus, retroverted, second trimester intrauterine fetal death, transvaginal ultrasound, ultrasound probe, uterine entrapment, uterine sacculation


Plan


 The authors report no conflict of interest.
 Funded by departmental funding.
 One of the cases in this series, along with an explanation of our transvaginal ultrasound probe technique, was presented as an oral presentation at AIUM's UltraCon 2023 in Orlando, FL, March 25 to 29, 2023.
 Cite this article as: Kantorowska A, Patberg ET, Ali F, et al. Incarcerated gravid uterus: a new treatment using the transvaginal ultrasound probe and narrative literature. Am J Obstet Gynecol 2024;XXX:XX–XX.


© 2024  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.